Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%

Follow WST

Alert me

Market cap: $27.0B
P/E: 48.7×
Fwd P/E: 37.3×
Dividend yield: 0.23%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	45.62	33.33	40.28	38.63	+8 more quarters Free account
P/S ratio Full definition →	7.64	5.60	6.47	6.28
P/FCF ratio Full definition →	58.69	39.73	42.77	50.47
P/Operating CF Full definition →	204.98	200.74	79.22	96.05
P/B ratio Full definition →	8.50	6.03	6.26	6.21
Price to Tangible BV Full definition →	8.84	6.28	6.50	6.46
EV/Sales Full definition →	7.57	5.50	6.28	6.13
EV/EBITDA Full definition →	29.22	21.32	25.52	24.59
EV/Operating CF Full definition →	38.03	24.78	25.58	26.69
EV/FCF Full definition →	58.15	39.03	41.51	49.33
Quick Ratio Full definition →	1.79	1.79	2.09	1.97
Current Ratio Full definition →	2.82	2.71	3.02	2.87
Net Debt/EBITDA Full definition →	(1.03)	(1.43)	(2.89)	(2.02)
Debt/Assets Full definition →	4.98%	4.93%	4.75%	4.94%
Debt/Equity Full definition →	0.07	0.07	0.06	0.07
Asset Turnover Full definition →	0.83	0.83	0.78	0.78
Operating CF/Net income Full definition →	0.81	0.65	1.90	1.41
Capex/Depreciation Full definition →	(0.94)	(0.94)	(1.62)	(1.47)
Interest Coverage Full definition →	68.88	93.21	(783.00)	838.00
Research and Development Expense of Revenue Full definition →	2.26%	1.87%	2.71%	2.13%
Selling, General and Administrative Expense of Revenue Full definition →	13.48%	11.78%	13.29%	12.76%
Intangible Assets out of Total Assets Full definition →	0.03	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →	1.25%	0.78%	0.83%	1.04%
Graham Net Nets Full definition →	0.03	0.04	0.04	0.04
Graham Number Full definition →	86.48	83.83	82.16	80.36
Earnings Yield Full definition →	2.19%	3.00%	2.48%	2.59%
Free Cash Flow Yield Full definition →	1.70%	2.52%	2.34%	1.98%
Revenue per Share Full definition →	12.32	11.73	11.13	11.14
Operating CF per Share Full definition →	1.75	1.25	3.47	2.73
Capex per Share Full definition →	(0.61)	(0.59)	(1.05)	(0.88)
Free Cash Flow per Share Full definition →	1.14	0.66	2.42	1.85
Cash per Share Full definition →	6.16	7.24	10.94	8.71
Shareholders Equity per Share Full definition →	42.23	41.53	43.93	42.26
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	42.23	41.53	43.93	42.26
Free Cash Flow Full definition →	80.80	47.20	175.00	133.90
Working Capital Full definition →	1,167.00	1,152.80	1,323.30	1,187.90
Capital Expenditures Full definition →	(43.20)	(42.70)	(76.10)	(63.30)
Net Current Asset Value Full definition →	721.30	707.40	884.20	769.00
EV/EBIT Full definition →	37.01	27.06	33.00	31.49
Capex to Sales Full definition →	0.05	0.05	0.09	0.08
Price to Operating Income Full definition →	37.36	27.55	34.01	32.22
Other line items
Average Receivables Full definition →	647.20	614.60	563.45	574.65
Average Payables Full definition →	245.85	240.35	246.50	240.05
Average Inventory Full definition →	434.25	420.65	410.45	419.60
Average Assets Full definition →	4,014.60	3,864.00	3,956.70	3,890.45
Average Common Equity Full definition →	2,959.65	2,836.75	2,929.15	2,901.80

Show all line items

Columns are period end dates

Stockrow Weekly